U.S. Viral Inactivation Market Size & Outlook, 2024-2030
U.S. viral inactivation market, 2018-2030 (US$M)
Related Markets
U.S. viral inactivation market highlights
- The U.S. viral inactivation market generated a revenue of USD 260.6 million in 2024 and is expected to reach USD 493.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.4% from 2025 to 2030.
- In terms of segment, kits and reagents was the largest revenue generating product & service in 2024.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Viral inactivation market data book summary
| Market revenue in 2024 | USD 260.6 million |
| Market revenue in 2030 | USD 493.5 million |
| Growth rate | 11.4% (CAGR from 2025 to 2030) |
| Largest segment | Kits and reagents |
| Fastest growing segment | Services |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits and reagents, Systems & Accessories, Services |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.3% of the global viral inactivation market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. viral inactivation market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 493.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viral Inactivation Market Scope
Viral Inactivation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. viral inactivation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral inactivation market will help companies and investors design strategic landscapes.
Kits and reagents was the largest segment with a revenue share of 63.39% in 2024. Horizon Databook has segmented the U.S. viral inactivation market based on kits and reagents, systems & accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. viral inactivation market dominated the global market in 2024. The growth can be attributed to the increasing R&D facilities and government initiatives. The high prevalence of various diseases and their requirement for treatment facilities has also surged market growth in the country. The U.S. viral clearance testing service providers have helped in upgrading of capabilities and infrastructure. The increase in funding has also driven the market growth.
Reasons to subscribe to U.S. viral inactivation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. viral inactivation market databook
-
Our clientele includes a mix of viral inactivation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. viral inactivation market , including forecasts for subscribers. This country databook contains high-level insights into U.S. viral inactivation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. viral inactivation market size, by product & service, 2018-2030 (US$M)
U.S. Viral Inactivation Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
